Foghorn Therapeutics (FHTX) Interest Coverage Ratio (2019 - 2021)
Foghorn Therapeutics (FHTX) recorded quarterly Interest Coverage Ratio of 65.92 in Q4 2021, down 25.26% quarter-over-quarter from 52.63 in Q3 2021, and down 1.84% on a YoY basis from 67.15 in Q4 2020.
Foghorn Therapeutics (FHTX) Interest Coverage Ratio (2019 - 2021) Analysis & Trends
Foghorn Therapeutics' Interest Coverage Ratio history runs 3 years deep, the most recent figure standing at 65.92 for Q4 2021.
- In Q4 2021, Interest Coverage Ratio fell 1.84% year-over-year to 65.92; the TTM figure through Sep 2022 stood at 266.04 (down 412.83% YoY), while the FY2021 annual figure was 52.85, up 24.5% from the prior year.
- Interest Coverage Ratio was 65.92 for Q4 2021 at Foghorn Therapeutics, down from 52.63 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 46.99 in Q2 2021 to a low of 115.93 in Q3 2019.
- Historically, Interest Coverage Ratio has averaged 70.23 across 3 years, with a median of 65.33 in 2020.
- Biggest YoY gain for Interest Coverage Ratio was 42.5% in 2021; the steepest drop was 1.84% in 2021.
- A 3-year view of Interest Coverage Ratio shows it stood at 85.31 in 2019, then advanced by 24.13% to 64.73 in 2020, then dropped by 1.84% to 65.92 in 2021.
- The last three Interest Coverage Ratio figures came in at 65.92 (Q4 2021), 52.63 (Q3 2021), and 46.99 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Foghorn Therapeutics | 282.33 Mn | 193.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -65.92 |
| Sep 30, 2021 | -52.63 |
| Jun 30, 2021 | -46.99 |
| Mar 31, 2021 | -47.59 |
| Dec 31, 2020 | -64.73 |
| Sep 30, 2020 | -91.53 |
| Jun 30, 2020 | -78.48 |
| Mar 31, 2020 | -53.19 |
| Dec 31, 2019 | -85.31 |
| Sep 30, 2019 | -115.93 |